The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
03 Feb 2022
Historique:
received: 12 01 2022
revised: 28 01 2022
accepted: 30 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 3 3 2022
Statut: epublish

Résumé

Retroelements (RE) have been proposed as important players in cancerogenesis. Different cancer types are characterized by a different level of tumor-specific RE insertions. In previous studies, small cohorts of hematological malignancies, such as acute myeloid leukemia, multiple myeloma, and chronic lymphocytic leukemia have been characterized by a low level of RE insertional activity. Acute lymphoblastic leukemia (ALL) in adults and childhood acute leukemias have not been studied in this context. We performed a search for new RE insertions (Alu and L1) in 44 childhood ALL, 14 childhood acute myeloid leukemia, and 14 adult ALL samples using a highly sensitive NGS-based approach. First, we evaluated the method sensitivity revealing the 1% detection threshold for the proportion of cells with specific RE insertion. Following this result, we did not identify new tumor-specific RE insertions in the tested cohort of acute leukemia samples at the established level of sensitivity. Additionally, we analyzed the transcription levels of active L1 copies and found them increased. Thus, the increased transcription of active L1 copies is not sufficient for overt elevation of L1 retrotranspositional activity in leukemia.

Identifiants

pubmed: 35163677
pii: ijms23031756
doi: 10.3390/ijms23031756
pmc: PMC8835895
pii:
doi:

Substances chimiques

DNA, Neoplasm 0
Retroelements 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Czech Science Foundation
ID : 19-11299S
Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2020-807

Références

N Engl J Med. 2017 Jul 27;377(4):361-370
pubmed: 28745987
Genome Res. 2019 Oct;29(10):1567-1577
pubmed: 31575651
BMC Bioinformatics. 2019 Jul 25;20(1):405
pubmed: 31345161
Semin Cancer Biol. 2010 Aug;20(4):200-10
pubmed: 20600922
Nat Commun. 2019 Sep 6;10(1):4022
pubmed: 31492840
Genome Res. 2006 Jan;16(1):78-87
pubmed: 16344559
Nature. 2001 Feb 15;409(6822):860-921
pubmed: 11237011
Nucleic Acids Res. 2005 Jan 26;33(2):e16
pubmed: 15673711
J Cell Biol. 2017 Nov 6;216(11):3535-3549
pubmed: 28887438
Science. 2014 Aug 01;345(6196):1251343
pubmed: 25082706
Science. 2012 Aug 24;337(6097):967-71
pubmed: 22745252
Genome Res. 2012 Dec;22(12):2328-38
pubmed: 22968929
Mol Cancer Res. 2018 Feb;16(2):279-285
pubmed: 29133595
Neuron. 2014 Jan 22;81(2):306-13
pubmed: 24389010
Nat Methods. 2011 Nov 20;9(1):72-4
pubmed: 22101854
Nat Struct Mol Biol. 2020 Feb;27(2):168-178
pubmed: 32042151
PLoS One. 2017 Sep 11;12(9):e0184507
pubmed: 28892497
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Mob DNA. 2020 Dec 14;11(1):33
pubmed: 33317630
PLoS One. 2015 Feb 17;10(2):e0117854
pubmed: 25689626
Cell. 2015 Apr 9;161(2):228-39
pubmed: 25860606
Genome Res. 2014 Jul;24(7):1053-63
pubmed: 24823667
Nucleic Acids Res. 2017 Jan 4;45(D1):D68-D73
pubmed: 27924012
Nucleic Acids Res. 2020 Apr 6;48(6):e36
pubmed: 32067044
Leukemia. 2003 Dec;17(12):2318-57
pubmed: 14562125
Mol Biol (Mosk). 2019 Jan-Feb;53(1):154-165
pubmed: 30895963
Cancer Genet Cytogenet. 1985 Feb 15;15(3-4):373-4
pubmed: 3971325
Mob DNA. 2018 Oct 31;9:31
pubmed: 30450130
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Leukemia. 2005 Nov;19(11):2016-8
pubmed: 16151462
Nat Genet. 2020 Mar;52(3):306-319
pubmed: 32024998
Cancer Res. 1992 Feb 1;52(3):643-5
pubmed: 1310068
Mob DNA. 2020 Feb 22;11:12
pubmed: 32110248
Cancers (Basel). 2021 Jan 14;13(2):
pubmed: 33466695
BMC Bioinformatics. 2012 Jun 18;13:134
pubmed: 22708584
Leukemia. 2019 Sep;33(9):2306-2340
pubmed: 30899083
PLoS One. 2016 Oct 5;11(10):e0163962
pubmed: 27706213
Nat Struct Mol Biol. 2006 Jul;13(7):655-60
pubmed: 16783376
Genome Biol. 2011 Dec 28;12(12):236
pubmed: 22204421
Mob DNA. 2016 Aug 11;7:16
pubmed: 27525044
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):449-54
pubmed: 15626757
Cell. 2013 Mar 28;153(1):101-11
pubmed: 23540693
Elife. 2016 Feb 22;5:
pubmed: 26901440

Auteurs

Shamil Urazbakhtin (S)

Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.

Anastasia Smirnova (A)

Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.
Center of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.

Anastasiya Volakhava (A)

Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.

Elena Zerkalenkova (E)

Dmitry Rogachev National Medical and Research Center of Pediatric Hematology, Oncology and Immunology, 117997 Moscow, Russia.

Maria Salyutina (M)

Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.

Michael Doubek (M)

Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.
Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.

Hana Jelinkova (H)

Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.

Nelly Khudainazarova (N)

Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.

Egor Volchkov (E)

Dmitry Rogachev National Medical and Research Center of Pediatric Hematology, Oncology and Immunology, 117997 Moscow, Russia.

Laima Belyaeva (L)

Dmitry Rogachev National Medical and Research Center of Pediatric Hematology, Oncology and Immunology, 117997 Moscow, Russia.

Ekaterina Komech (E)

Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.

Sarka Pavlova (S)

Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.

Yuri Lebedev (Y)

Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.

Karla Plevova (K)

Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.
Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.

Yulia Olshanskaya (Y)

Dmitry Rogachev National Medical and Research Center of Pediatric Hematology, Oncology and Immunology, 117997 Moscow, Russia.

Alexander Komkov (A)

Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.
Dmitry Rogachev National Medical and Research Center of Pediatric Hematology, Oncology and Immunology, 117997 Moscow, Russia.

Ilgar Mamedov (I)

Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.
Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
Dmitry Rogachev National Medical and Research Center of Pediatric Hematology, Oncology and Immunology, 117997 Moscow, Russia.
Department of Molecular Technologies, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH